Connect Investigative Site 101 — Sherman, Texas

Connect Investigative Site 101 is a clinical research site located in Sherman, Texas, United States 75092.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Connect Investigative Site 101 has participated in 1 clinical trials.

Therapeutic areas: Chronic Rhinosinusitis With Nasal Polyps.

Sponsors: Connect Biopharm LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Sherman

Browse all research sites in Texas · View every site in Sherman

• Texas Cancer Center-Sherman
• Sherman Clinical Research
• Research Site
• Texas Institute for Neurological Disorders
• Texas Oncology-Sherman
• Texas Oncology, PA at Texas Cancer Center - Sherman
• Novartis Investigative Site
• GSK Investigational Site
• Texas Institute for Neurological Disorders - Sherman
• Revival Research Institute, LLC
• Clinical Trial Site
• Medrasa Clinical Research

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Connect Investigative Site 101?

Connect Investigative Site 101 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Connect Investigative Site 101 conducted?

Connect Investigative Site 101 has 1 clinical trials on record. Their work covers Chronic Rhinosinusitis With Nasal Polyps.

Is Connect Investigative Site 101 accredited by Crixeo Clinical Trials?

Connect Investigative Site 101 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Connect Investigative Site 101?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.